Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Revista De Neurologia
|
August 5, 2000
[What treatment should be given for multiple sclerosis at the present time?]
C Ramo-Tello, T León-Colombo
Neurologia (Barcelona, Spain)
|
July 4, 2008
[Communication of the diagnosis of multiple sclerosis: the patient's opinion]
L Grau López, C Ramo Tello
Neurologia (Barcelona, Spain)
|
December 18, 2010
Analysis of the pain in multiple sclerosis patients
L Grau-López, S Sierra, E Martínez-Cáceres, et al.
European Neurology
|
January 8, 2011
Adherence to disease-modifying therapies in spanish patients with relapsing multiple sclerosis: two-year interim results of the global adherence project
E Arroyo, C Grau, C Ramo-Tello, et al.
Neurologia (Barcelona, Spain)
|
September 19, 2015
Myelitis: Differences between multiple sclerosis and other aetiologies
S Presas-Rodríguez, L Grau-López, J V Hervás-García, et al.
American Journal of Medical Genetics
|
June 19, 1995
Familial cosegregation of manic-depressive illness and a form of hereditary cerebellar ataxia
J Fernández Piqueras, J Santos, G Visedo, et al.
Autoimmunity Reviews
|
April 28, 2009
Myelin peptides in multiple sclerosis
L Grau-López, D Raïch, C Ramo-Tello, et al.
European Journal of Neurology
|
July 14, 2011
Specific T-cell proliferation to myelin peptides in relapsing-remitting multiple sclerosis
L Grau-López, D Raïch, C Ramo-Tello, et al.
Journal of Translational Medicine
|
June 11, 2011
Comparative study of clinical grade human tolerogenic dendritic cells
M Naranjo-Gómez, D Raïch-Regué, C Oñate, et al.
European Journal of Neurology
|
June 22, 2010
The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis
V Devonshire, Y Lapierre, R Macdonell, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Revista De Neurologia
|
August 5, 2000
[What treatment should be given for multiple sclerosis at the present time?]
C Ramo-Tello, T León-Colombo
Neurologia (Barcelona, Spain)
|
July 4, 2008
[Communication of the diagnosis of multiple sclerosis: the patient's opinion]
L Grau López, C Ramo Tello
Neurologia (Barcelona, Spain)
|
December 18, 2010
Analysis of the pain in multiple sclerosis patients
L Grau-López, S Sierra, E Martínez-Cáceres, et al.
European Neurology
|
January 8, 2011
Adherence to disease-modifying therapies in spanish patients with relapsing multiple sclerosis: two-year interim results of the global adherence project
E Arroyo, C Grau, C Ramo-Tello, et al.
Neurologia (Barcelona, Spain)
|
September 19, 2015
Myelitis: Differences between multiple sclerosis and other aetiologies
S Presas-Rodríguez, L Grau-López, J V Hervás-García, et al.
American Journal of Medical Genetics
|
June 19, 1995
Familial cosegregation of manic-depressive illness and a form of hereditary cerebellar ataxia
J Fernández Piqueras, J Santos, G Visedo, et al.
Autoimmunity Reviews
|
April 28, 2009
Myelin peptides in multiple sclerosis
L Grau-López, D Raïch, C Ramo-Tello, et al.
European Journal of Neurology
|
July 14, 2011
Specific T-cell proliferation to myelin peptides in relapsing-remitting multiple sclerosis
L Grau-López, D Raïch, C Ramo-Tello, et al.
Journal of Translational Medicine
|
June 11, 2011
Comparative study of clinical grade human tolerogenic dendritic cells
M Naranjo-Gómez, D Raïch-Regué, C Oñate, et al.
European Journal of Neurology
|
June 22, 2010
The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis
V Devonshire, Y Lapierre, R Macdonell, et al.
Page
of 3